Why is Senores Pharma. falling/rising?

As of 03-Jul, Senores Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 570.50, which reflects a decrease of 10.0 points or 1.72%. The stock has underperformed its sector by 2.2% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of 2.31% during this period. Despite touching an intraday high of Rs 593.2, the stock's performance over the past month shows a positive return of 9.67%, although it has generated no returns over the past year. The company has a low Debt to Equity ratio and has shown healthy long-term growth, with net sales increasing at an annual rate of 85.60% and operating profit at 130.72%. However, the stock's valuation appears expensive with a Price to Book Value of 3.3, and there has been a notable decrease in institutional investor participation, which has fallen by 10.3% over the previous quarter.
In the broader market context, the stock's short-term performance over the past week shows a decline of 0.60%, which is slightly better than the Sensex's decline of 0.62%. While the stock has shown positive returns over the past month, the recent drop in investor participation and the flat results reported for December 2024 may be contributing to the current downward pressure on the stock price. The overall market sentiment appears to be cautious, especially with institutional investors, who typically have more resources to analyze company fundamentals, reducing their stakes in Senores Pharmaceuticals.